On August 19, Shanghai Enterprise Federation, Shanghai Entrepreneur Association, Shanghai Federation of Economic Organizations and Jiefang Daily jointly released the list of Top 100 Enterprises in Shanghai of 2019. With outstanding market performance and excellent corporate strength, Haohai Biological Technology Co. Ltd. was included in the list of "Top 100 Enterprises in Shanghai" for the first time, and won the two awards of "2019 Top 100 Manufacturing Enterprises in Shanghai" and "2019 Top 100 Private Manufacturing Enterprises in Shanghai". Among the biopharmaceutical companies included in the Top 100 list, Haohai Biological Technology Co. Ltd. ranked the 4th and the 2nd in "2019 Top 100 Manufacturing Enterprises in Shanghai" and "2019 Top 100 Private Manufacturing Enterprises in Shanghai".
 

Operation and Growth of Enterprise

For Haohai Biological Technology Co. Ltd., which was included in the list for the first time, its operating income has exceeded RMB1.5 billion and net profit reached RMB415 million after only 11 years of establishment. Its products of viscosupplementation products, ophthalmic viscoelastic devices and other products, through more than ten years of continuous cultivation, breaking the import monopoly situation, have successfully occupied the leading position in the domestic market segment. In addition, since 2015, Haohai Biological Technology Co. Ltd. has acquired the intraocular lens and ophthalmology materials companies with advanced production technologies and strong R&D platforms at home and abroad to achieve the integration of upstream and downstream of intraocular lens industry chain, gradually realize the pursuit and surpass of domestic intraocular lens technology over overseas advanced technologies, and break the monopoly of imported brands in intraocular lens market for a long time.
 

As a local Shanghai bio-pharmaceutical company, Haohai Biological Technology Co. Ltd. has been rooted in Shanghai and thrives on the G60 Scientific Innovation Corridor. At the beginning of this year, "Shanghai Haohai Biological Technology Co. Ltd. International Pharmaceutical R&D and Industrialization Project" was written into the Shanghai 2019 Government Work Report. On March 14, the Project held the groundbreaking ceremony in the state-level Shanghai Songjiang Economic and Technological Development Zone.
 

At present, Haohai Biological Technology Co. Ltd. is mainly engaged in more than 30 research projects, including a number of blockbuster products such as orthokeratology lenses, high-end intraocular lenses and innovative skin fillers. In the future, Haohai Biological Technology Co. Ltd. will continue to build an engine for the future development of the enterprise with technological innovation, serve the patients with better products and return the investors with better performance.